Furthermore, diabetes- or oxidative stress-induced decreases in NO formation were prevented by deletion of NOX2 in vivo (Figure 2) or blockade of NOX2 in vitro (Figure 7), suggesting a causal link between NOX2-induced arginase activation and suppression of NO bioavailability. Here, CYBB is linked to diabetes mellitus.